SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-10-007517
Filing Date
2010-04-28
Accepted
2010-04-28 19:08:41
Documents
2
Period of Report
2010-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1617
2 POWER OF ATTORNEY ringrose-poa.txt EX-24.TXT 3360
  Complete submission text file 0001179110-10-007517.txt   6816
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164
Business Address
RINGROSE PETER S (Reporting) CIK: 0001199298 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 10778390